Behavioural and neurochemical response of α-synuclein A30P transgenic mice to the effects of L-DOPA

被引:16
|
作者
Oksman, Mari [2 ]
Tanila, Heikki [3 ,4 ]
Yavich, Leonid [1 ,3 ]
机构
[1] Univ Kuopio, Dept Pharmacol & Toxicol, In Vivo Voltammetry Contract Res Lab, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Neurosci & Neurol, FIN-70211 Kuopio, Finland
[3] Univ Kuopio, Dept Neurobiol, AI Virtanen Inst, FIN-70211 Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland
基金
芬兰科学院;
关键词
A30P mutation; alpha-Synuclein; Behaviour; Dopamine overflow; Nucleus accumbens shell; L-DOPA; PARKINSONS-DISEASE; STORAGE POOLS; PATHOGENESIS; STRIATUM; VESICLES; RELEASE;
D O I
10.1016/j.neuropharm.2008.11.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transgenic mice carrying human A30P mutated alpha-synuclein demonstrate hypolocomotion and dysfunction of the presynaptic machinery of dopamine overflow, induced by reducing capacity of the dopamine storage pool. We suggested that overexpression of alpha-synuclein may change sensitivity of these mice to L-DOPA. Current study assessed behavioural and neurochemical responses in A30P mice to L-DOPA using automated activity monitoring and voltammetry. We confirmed decreased locomotion and rearing of A30P transgenic mice compared to wild-type controls. L-DOPA (10-200 mg/kg, i.p.) dose-dependently lowered locomotor activity, including stereotypy, in both genotypes, but the effects were larger in A30P mice. The effects of drug on stimulated dopamine overflow were investigated in the nucleus accumbens shell. L-DOPA at the dose of 30 mg/kg did not change peak dopamine overflow induced by 10 Hz stimulation of the medial forebrain bundle in either genotype, but increased it at the higher (20-50 Hz) frequencies of stimulation. At the higher frequencies of stimulation, L-DOPA elevated dopamine overflow significantly more in A30P mice than in the control animals. These data show that A30P transgenic mice are more sensitive to the effects of L-DOPA at both behavioural and neurochemical level. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:647 / 652
页数:6
相关论文
共 50 条
  • [1] A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice
    Szego, Eva M.
    Gerhardt, Ellen
    Kermer, Pawel
    Schulz, Joerg B.
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 591 - 600
  • [2] Behavioral changes in transgenic A30P α-synuclein mutation mice
    Oksman, M
    Puoliväli, J
    Jäkälä, P
    Tanita, H
    Beyreuther, K
    Hartmann, T
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S244 - S244
  • [3] Abnormal α-synuclein interactions with rab proteins in α-synuclein A30P transgenic mice
    Dalfó, E
    Gómez-Isla, T
    Rosa, JL
    Bodelón, MN
    Tejedor, MC
    Barrachina, M
    Ambrosio, S
    Ferrer, I
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (04): : 302 - 313
  • [4] Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice
    Nieto, María
    Gil-Bea, Francisco J.
    Dalfó, Esther
    Cuadrado, Mar
    Cabodevilla, Felipe
    Sanchez, Belén
    Catena, Silvia
    Sesma, Teresa
    Ribe, Elena
    Ferrer, Isidro
    Ramirez, María J.
    Gomez-Isla, Teresa
    [J]. NEUROBIOLOGY OF AGING, 2006, 27 (06) : 848 - 856
  • [5] Investigation of [A30P]α-synuclein transgenic mice in tests of motor performance and cognition
    Freichel, CP
    Ozmen, L
    Kahle, PJ
    Ballard, TM
    Spooren, W
    [J]. BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S36 - S36
  • [6] Intracellular α-synuclein (α-syn) accumulation in transgenic mice expressing A30P α-syn mutation
    Jakala, P
    Puolivali, J
    Kerokoski, P
    van Groen, T
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S252 - S252
  • [7] Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α-synuclein knockout and A30P transgenic mice
    Yavich, Leonid
    Jakala, Pekka
    Tanila, Heikki
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 99 (03) : 724 - 732
  • [8] Motor dysfunction and gliosis with preserved dopaminergic markers in human α-synuclein A30P transgenic mice
    Gomez-Isla, T
    Irizarry, MC
    Mariash, A
    Cheung, B
    Soto, O
    Schrump, S
    Sondel, J
    Kotilinek, L
    Day, J
    Schwarzschild, MA
    Cha, JHJ
    Newell, K
    Miller, DW
    Uéda, K
    Young, AB
    Hyman, BT
    Ashe, KH
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 245 - 258
  • [9] MicroRNA and proteome expression profiling in early-symptomatic α-synuclein(A30P)-transgenic mice
    Gillardon, Frank
    Mack, Matthias
    Rist, Wolfgang
    Schnack, Cathrin
    Lenter, Martin
    Hildebrandt, Tobias
    Hengerer, Bastian
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (05) : 697 - 705
  • [10] Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l
    Yan, Jianguo
    Zhang, Pei
    Jiao, Fengjuan
    Wang, Qingzhi
    He, Feng
    Zhang, Qian
    Zhang, Zheng
    Lv, Zexi
    Peng, Xiang
    Cai, Hongwei
    Tian, Bo
    [J]. PLOS ONE, 2017, 12 (08):